CN1229389C - Immunomagnetic Separation Technology of Purifying Gene Engineering Recombinant Interferon - Google Patents
Immunomagnetic Separation Technology of Purifying Gene Engineering Recombinant Interferon Download PDFInfo
- Publication number
- CN1229389C CN1229389C CN 03144274 CN03144274A CN1229389C CN 1229389 C CN1229389 C CN 1229389C CN 03144274 CN03144274 CN 03144274 CN 03144274 A CN03144274 A CN 03144274A CN 1229389 C CN1229389 C CN 1229389C
- Authority
- CN
- China
- Prior art keywords
- add
- magnetic
- preparation
- interferon
- microspheres
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Peptides Or Proteins (AREA)
Abstract
本发明涉及一种基因工程重组蛋白的分离技术,特别是利用免疫磁性分离技术分离纯化基因工程重组干扰素(interferon,IFN),属于生物技术领域。本发明采用不同材料制备含有羟基的磁性微球,经环氧氯丙烷活化后,导入活性氨基,用戊二醛作为连接臂与抗干扰素抗体连接,即得到可用于干扰素分离纯化的免疫磁性微球。用该免疫磁性微球和磁性分离装置对基因工程重组干扰素的发酵菌体裂解液进行分离纯化,活性回收率超过50%,纯化后的干扰素比活性高于1.0×108IU/mg,SDS-PAGE凝胶电泳分析纯度接近100%。The invention relates to a separation technology of genetic engineering recombinant protein, in particular to the separation and purification of genetic engineering recombinant interferon (interferon, IFN) by using immunomagnetic separation technology, and belongs to the field of biotechnology. The present invention uses different materials to prepare magnetic microspheres containing hydroxyl groups. After being activated by epichlorohydrin, active amino groups are introduced, and glutaraldehyde is used as a linking arm to connect with anti-interferon antibodies to obtain an immunomagnetic microsphere that can be used for the separation and purification of interferon. Microspheres. The immunomagnetic microspheres and magnetic separation device were used to separate and purify the fermented cell lysate of genetically engineered recombinant interferon, the activity recovery rate was over 50%, and the specific activity of the purified interferon was higher than 1.0×10 8 IU/mg, The purity of SDS-PAGE gel electrophoresis analysis was close to 100%.
Description
技术领域technical field
本发明涉及一种基因工程重组蛋白的分离技术,特别是利用免疫磁性分离技术纯化干扰素,属于生物技术领域。The invention relates to a separation technology of genetically engineered recombinant protein, in particular to the purification of interferon by using the immunomagnetic separation technology, and belongs to the field of biotechnology.
背景技术Background technique
干扰素(Interferon,IFN)是机体受外源刺激产生的一类调节蛋白,具有广谱抗病毒、抗肿瘤和免疫调节活性。在临床上对病毒性肝炎、带状疱疹、淋巴瘤、白血病等均有一定的疗效。基因重组人干扰素α-2b(α-2bIFN)作为最早的基因重组蛋白质类药物之一,1986年即在欧美上市(美国Schering-Plough公司)。1990年,国内通过自主研制及引进国外技术,相继有多家企业投入商业化生产,目前国内市场年销售额已达10亿元,美国年销售额20多亿美元。基因重组人干扰素主要利用基因工程菌发酵生产,系胞内活性表达产物,分离纯化过程复杂,要经过细胞破碎、离心分离、盐析沉淀、溶解沉淀、疏水层析、阴阳离子交换层析和凝胶过滤层析等过程。由于分离过程步骤多,造成产品收率较低、成本高。目前,一些公司通常采用亲和层析以提高纯化效率和特异性,但在亲和层析之前也要经过盐析、疏水或离子交换层析等处理才能获得较高的纯化效率。另外,亲和层析介质同特异性抗体的连接多采用巨毒的溴化氰作为偶联剂,增加了工艺的危险性。目前国内外各企业均致力于干扰素分离纯化的新技术的开发与生产工艺的更新。Interferon (Interferon, IFN) is a kind of regulatory protein produced by the body in response to exogenous stimuli, and has broad-spectrum antiviral, antitumor and immunomodulatory activities. Clinically, it has a certain curative effect on viral hepatitis, herpes zoster, lymphoma, leukemia, etc. Gene recombinant human interferon α-2b (α-2bIFN), as one of the earliest gene recombinant protein drugs, was launched in Europe and America in 1986 (Schering-Plough Company, USA). In 1990, through independent research and introduction of foreign technology in China, many enterprises successively put into commercial production. At present, the annual sales in the domestic market have reached 1 billion yuan, and the annual sales in the United States have exceeded 2 billion US dollars. Recombinant human interferon is mainly produced by the fermentation of genetically engineered bacteria. It is an active expression product in cells. The separation and purification process is complicated. gel filtration chromatography etc. Due to the many steps in the separation process, the product yield is low and the cost is high. At present, some companies usually use affinity chromatography to improve purification efficiency and specificity, but prior to affinity chromatography, salting-out, hydrophobic or ion-exchange chromatography must be performed to obtain higher purification efficiency. In addition, highly toxic cyanogen bromide is often used as a coupling agent for the connection between the affinity chromatography medium and the specific antibody, which increases the risk of the process. At present, all enterprises at home and abroad are committed to the development of new technologies for the separation and purification of interferon and the update of production processes.
发明内容Contents of the invention
本发明的目的是为蛋白类基因工程产物的分离纯化开辟一条新的途径,涉及纯化基因工程重组干扰素的磁性微球的制备、活化和致敏,以及磁性分离装置的制备。The purpose of the present invention is to open up a new approach for the separation and purification of protein genetic engineering products, which involves the preparation, activation and sensitization of magnetic microspheres for purifying genetic engineering recombinant interferon, and the preparation of magnetic separation devices.
本发明采用琼脂糖、聚乙烯醇、纤维素等材料分别制备了表面带有羟基的磁性微球,以环氧氯丙烷对微球进行活化,导入活性氨基后,并采用戊二醛作为连接臂与抗干扰素IgG抗体连接,得到可用于干扰素分离纯化的免疫磁性微球。所使用的抗干扰素IgG抗体可以是经纯化精制的抗干扰素单克隆或多克隆IgG抗体。The present invention uses agarose, polyvinyl alcohol, cellulose and other materials to prepare magnetic microspheres with hydroxyl groups on the surface, activates the microspheres with epichlorohydrin, introduces active amino groups, and uses glutaraldehyde as the connecting arm Link with anti-interferon IgG antibody to obtain immunomagnetic microspheres that can be used for separation and purification of interferon. The anti-interferon IgG antibody used may be a purified anti-interferon monoclonal or polyclonal IgG antibody.
用上述免疫磁性微球和磁性分离装置对干扰素的发酵菌体裂解液或预处理的菌体裂解液进行免疫磁性分离,活性回收率超过50%,纯化后的人干扰素(IFN)比活性高于1.0×108IU/mg,SDS-PAGE凝胶电泳分析纯度接近100%,符合国家标准。纯化后样品中动物源性抗体含量低于国家规定的每个剂量100ng以下的要求。Use the above-mentioned immunomagnetic microspheres and magnetic separation device to carry out immunomagnetic separation on the fermented cell lysate or pretreated cell lysate of interferon, the activity recovery rate exceeds 50%, and the specific activity of purified human interferon (IFN) Higher than 1.0×10 8 IU/mg, the purity of SDS-PAGE gel electrophoresis analysis is close to 100%, which meets the national standard. The animal-derived antibody content in the purified sample is lower than the national requirement of 100ng per dose.
本发明的有益效果是:利用该免疫磁性分离技术纯化基因工程重组干扰素(IFN),操作简便、快速,无须对样品进行复杂的前处理,可以直接从发酵菌体的裂解液中,一步纯化得到高纯度的目的蛋白,大大简化分离纯化的步骤,提高产品收率。分离纯化条件温和,该免疫磁性微球可重复使用10次以上。本发明可望替代免疫亲和层析柱,成为一种快速、高效分离纯化干扰素的新技术。The beneficial effects of the present invention are: using the immunomagnetic separation technology to purify the genetically engineered recombinant interferon (IFN), the operation is simple and fast, and there is no need to perform complicated pretreatment on the sample, and it can be directly purified in one step from the lysate of fermented cells The high-purity target protein is obtained, the steps of separation and purification are greatly simplified, and the product yield is improved. The separation and purification conditions are mild, and the immunomagnetic microspheres can be reused more than 10 times. The invention is expected to replace the immunoaffinity chromatography column and become a new technology for fast and efficient separation and purification of interferon.
附图说明Description of drawings
图1磁性微球的扫描电镜照片Fig.1 Scanning electron micrograph of magnetic microspheres
其中A图为琼脂糖磁性微球(×1500);B图为纤维素磁性微球(×1200);C图为聚乙烯醇磁性微球(×300)。Among them, picture A shows agarose magnetic microspheres (×1500); picture B shows cellulose magnetic microspheres (×1200); picture C shows polyvinyl alcohol magnetic microspheres (×300).
图2磁性分离装置示意图Figure 2 Schematic diagram of magnetic separation device
其中(1)柱状的反应密封容器;(2)免疫磁性微球;(3)磁铁;(4)末端出液阀;(5)反应液;(6)上端通气阀;(7)收集容器。Wherein (1) a columnar reaction sealed container; (2) immunomagnetic microspheres; (3) a magnet; (4) a liquid outlet valve at the end; (5) a reaction liquid; (6) an upper vent valve; (7) a collection container.
图3干扰素的SDS-PAGE凝胶电泳分析Figure 3 SDS-PAGE gel electrophoresis analysis of interferon
图中各泳道条件为:泳道a:标准分子量蛋白;泳道b:α-2b干扰素发酵菌体裂解液;泳道c:硫胺沉淀处理的菌体裂解液;泳道d:琼脂糖免疫磁性微球分离结果;泳道e:纤维素免疫磁性微球分离结果;泳道f:聚乙烯醇免疫磁性微球分离结果。The conditions of each lane in the figure are: lane a: standard molecular weight protein; lane b: lysate of α-2b interferon fermented bacteria; lane c: lysate of bacteria treated with thiamine precipitation; lane d: agarose immunomagnetic microspheres Separation results; lane e: separation results of cellulose immunomagnetic microspheres; lane f: separation results of polyvinyl alcohol immunomagnetic microspheres.
具体实施方式Detailed ways
一.抗干扰素IgG抗体的制备:1. Preparation of anti-interferon IgG antibody:
1)Anti-IFN血清的制备:1) Preparation of Anti-IFN serum:
取人干扰素(IFN)标准品,与等体积的弗氏完全佐剂充分混合乳化即得人干扰素(IFN)抗原,取人干扰素(IFN)抗原,分别对2只日本大耳白雄性家兔(体重2Kg)肌肉及皮下进行多点注射。追加注射采用弗氏不完全佐剂乳化制备抗原,每隔两周加强注射一次,共三次,剂量递减。最后一次免疫3天后静脉取血,用间接ELISA法测定抗体效价,测得血清的抗体中和效价为大于1∶10000后,腹动脉放血,将全血静置2小时,3000rpm离心20分钟,收集血清于55℃水浴中灭活30分钟,分装后于-20℃冷冻保存;Take human interferon (IFN) standard substance, fully mix and emulsify with an equal volume of Freund's complete adjuvant to obtain human interferon (IFN) antigen, take human interferon (IFN) antigen, and treat 2 Japanese white-eared males respectively Rabbits (body weight 2Kg) were intramuscularly and subcutaneously injected at multiple points. The additional injection was prepared by emulsifying the antigen with Freund's incomplete adjuvant, and the booster injection was performed once every two weeks, for a total of three times, with the dose decreasing. Three days after the last immunization, blood was taken from the vein, and the antibody titer was determined by indirect ELISA method. The neutralizing titer of the antibody in the serum was measured to be greater than 1:10000. After that, the abdominal artery was bled, and the whole blood was left to stand for 2 hours and centrifuged at 3000rpm for 20 minutes. , collect the serum and inactivate it in a water bath at 55°C for 30 minutes, then freeze it at -20°C after aliquoting;
2)Anti-IFN IgG抗体的纯化:2) Purification of Anti-IFN IgG antibody:
取Anti-IFN血清,加入等体积的PBS混匀后,分别加入等体积的饱和硫铵沉淀,离心收集沉淀,沉淀物溶于PBS中,4℃透析过夜,得到粗提的Anti-IFN免疫球蛋白,将上述免疫球蛋白粗品,采用DEAE-cellulose 52离子交换层析进行梯度洗脱,收集合并IgG洗脱峰,经蒸馏水透析,冷冻干燥后得精制兔抗干扰素IgG多克隆抗体。Take Anti-IFN serum, add an equal volume of PBS to mix well, add an equal volume of saturated ammonium sulfate to precipitate, centrifuge to collect the precipitate, dissolve the precipitate in PBS, and dialyze overnight at 4°C to obtain crude anti-IFN immune spheres For the protein, the crude immunoglobulin was subjected to gradient elution using DEAE-cellulose 52 ion exchange chromatography, and the combined IgG elution peaks were collected, dialyzed with distilled water, and freeze-dried to obtain a refined rabbit anti-interferon IgG polyclonal antibody.
二.免疫磁性微球的制备:2. Preparation of immunomagnetic microspheres:
磁性微球,包括反相物理包埋法制备的琼脂糖磁性微球和纤维素磁性微球,反相悬浮交联法制备的聚乙烯醇磁性微球等含有活性羟基基团的磁性微球;制备工艺包括下属过程:Magnetic microspheres, including agarose magnetic microspheres and cellulose magnetic microspheres prepared by reverse-phase physical embedding method, polyvinyl alcohol magnetic microspheres prepared by reverse-phase suspension cross-linking method and other magnetic microspheres containing active hydroxyl groups; The preparation process includes the following processes:
1)磁流体的制备:1) Preparation of magnetic fluid:
取FeCl2·4H2O溶于去离子水中,经微孔滤膜过滤除杂质,然后加入一定量的聚乙二醇和双氧水,混匀后用NaOH溶液调至pH9~11,在50~80℃水浴中反应3~6小时,得到棕黑色磁性胶体粒子的稳定悬浮液即磁流体;Dissolve FeCl 2 4H 2 O in deionized water, filter through a microporous membrane to remove impurities, then add a certain amount of polyethylene glycol and hydrogen peroxide, mix well, adjust the pH to 9~11 with NaOH solution, and set the temperature at 50~80℃ React in a water bath for 3 to 6 hours to obtain a stable suspension of brown-black magnetic colloidal particles, that is, magnetic fluid;
2)琼脂糖磁性微球的制备:2) Preparation of agarose magnetic microspheres:
取甲苯,四氯化碳以及Span-80,预热至60~80℃,作为有机相;将一定量的磁流体加入到琼脂糖溶液中,于沸水浴中加热溶解,并迅速转移至有机相中,在2000~5000rpm搅拌下反应5~30分钟后,迅速冷却至室温;最后用乙醚、蒸馏水清洗,筛分粒径在100~300μm之间的琼脂糖磁性微球,于2~8℃保存备用。Take toluene, carbon tetrachloride and Span-80, preheat to 60 ~ 80 ℃, as the organic phase; add a certain amount of magnetic fluid to the agarose solution, heat to dissolve in a boiling water bath, and quickly transfer to the organic phase After reacting for 5-30 minutes under stirring at 2000-5000rpm, cool down to room temperature rapidly; finally wash with ether and distilled water, sieve the agarose magnetic microspheres with a particle size between 100-300μm, and store them at 2-8°C spare.
3)聚乙烯醇磁性微球的制备:3) Preparation of polyvinyl alcohol magnetic microspheres:
取200#汽油、四氯化碳以及Span-80混匀,作为有机相;配制一定浓度聚乙烯醇溶液,加入一定量的磁流体,冰浴5~20分钟,加入戊二醛溶液和盐酸,混匀后迅速倒入有机相中,在2000~5000rpm下分散0.5~2小时,缓慢升温至60~80℃再继续反应1~3小时;最后用乙醚、蒸馏水淋洗,筛分粒径在100~300μm之间的聚乙烯醇磁性微球,于2~8℃保存备用;Mix 200 # gasoline, carbon tetrachloride and Span-80 as the organic phase; prepare a certain concentration of polyvinyl alcohol solution, add a certain amount of magnetic fluid, ice bath for 5 to 20 minutes, add glutaraldehyde solution and hydrochloric acid, After mixing, quickly pour into the organic phase, disperse at 2000-5000rpm for 0.5-2 hours, slowly raise the temperature to 60-80°C and continue the reaction for 1-3 hours; finally rinse with ether and distilled water, and sieve the particle size at 100 Polyvinyl alcohol magnetic microspheres between ~300 μm, stored at 2~8 ℃ for later use;
4)纤维素磁性微球的制备:4) Preparation of cellulose magnetic microspheres:
将NaOH溶液加入到一定量的脱脂棉中,浸泡1~4小时,挤去碱液,10~30℃下老化后,加入一定量的二硫化碳混匀,密封后继续反应2~8小时,再加入一定浓度的NaOH溶液反应5~10小时,得到橙红色的黄原酸酯粘胶液;取氯苯、四氯化碳和油酸钾,20~50℃水浴搅拌混匀后,加入一定量溶有磁流体的黄原酸酯粘胶液,在2000~5000rpm下分散20~60分钟后升温至75~100℃,再继续反应1~4小时;最后用乙醚、蒸馏水淋洗,筛分粒径在100~300μm之间的纤维素磁性微球,于2~8℃保存备用。Add NaOH solution to a certain amount of absorbent cotton, soak for 1-4 hours, squeeze out the lye, after aging at 10-30°C, add a certain amount of carbon disulfide and mix well, continue to react for 2-8 hours after sealing, and then add some Concentrated NaOH solution was reacted for 5 to 10 hours to obtain orange-red xanthate viscose; take chlorobenzene, carbon tetrachloride and potassium oleate, stir and mix in a water bath at 20 to 50°C, and then add a certain amount of dissolved Xanthate viscose solution of magnetic fluid, disperse at 2000-5000rpm for 20-60 minutes, then heat up to 75-100°C, and continue to react for 1-4 hours; finally rinse with ether and distilled water, and sieve the particle size at Cellulose magnetic microspheres between 100-300 μm are stored at 2-8°C for later use.
5)磁性微球的活化:5) Activation of magnetic microspheres:
取一定量的磁性微球在碱性条件下加入一定体积的环氧氯丙烷,在25~40℃下进行活化2~4小时,洗净环氧氯丙烷后加入2~20%氨水,室温反应3~9小时,充分淋洗后再加2~20%戊二醛溶液,室温反应1~5小时,最后用蒸馏水洗掉过量的戊二醛。Take a certain amount of magnetic microspheres, add a certain volume of epichlorohydrin under alkaline conditions, activate at 25-40°C for 2-4 hours, add 2-20% ammonia water after washing the epichlorohydrin, and react at room temperature After 3-9 hours, fully rinse and then add 2-20% glutaraldehyde solution, react at room temperature for 1-5 hours, and finally wash off excess glutaraldehyde with distilled water.
6)磁性微球的致敏:6) Sensitization of magnetic microspheres:
在2~8℃下,取一定量的活化好的磁性微球,加入含有抗干扰素的单克隆或多克隆IgG抗体的NaHCO3-NaCO3缓冲液,充分反应后经PBS淋洗,加入NaBH4进行还原,然后用PBS洗净即得到可用于纯化干扰素(IFN)的免疫磁性微球,抗体偶联量为3~15mg/mL球。At 2-8°C, take a certain amount of activated magnetic microspheres, add NaHCO 3 -NaCO 3 buffer solution containing anti-interferon monoclonal or polyclonal IgG antibodies, fully react, rinse with PBS, add NaBH 4. Perform reduction, and then wash with PBS to obtain immunomagnetic microspheres that can be used to purify interferon (IFN), and the antibody coupling amount is 3-15 mg/mL spheres.
三.干扰素(IFN)的免疫磁性分离:3. Immunomagnetic separation of interferon (IFN):
取免疫磁性微球经PBS充分清洗后,置于磁性分离装置的容器中;加入用缓冲液稀释的基因工程重组干扰素(IFN)的发酵菌体裂解液或预处理的裂解液,于2~8℃缓慢振荡反应3~24小时,反应后将容器置于磁性分离装置上,吸附固定磁性微球,弃去反应液,经PBS清洗后再加入甘氨酸-盐酸缓冲液(pH1.5~3.5),于2~8℃缓慢振荡反应1~5小时用于解离吸附的干扰素(IFN),再将玻璃容器置于分离装置上,吸附磁性微球,收集解离液,立即用高浓度的PB缓冲液(pH6.5~8.0)中和,得到纯化的基因工程重组干扰素(IFN)。免疫磁性微球用PBS清洗后,于2~8℃保存可重复使用。Take the immunomagnetic microspheres and wash them thoroughly with PBS, then place them in the container of the magnetic separation device; add the fermented cell lysate or pretreated lysate of the genetically engineered recombinant interferon (IFN) diluted with buffer solution, and in 2~ Slowly shake and react at 8°C for 3 to 24 hours. After the reaction, place the container on a magnetic separation device, absorb and fix the magnetic microspheres, discard the reaction solution, wash with PBS, and then add glycine-hydrochloric acid buffer (pH1.5 to 3.5) , slowly shaking and reacting at 2-8°C for 1-5 hours to dissociate the adsorbed interferon (IFN), then place the glass container on the separation device, absorb the magnetic microspheres, collect the dissociation solution, and immediately use high-concentration PB buffer (pH 6.5-8.0) is neutralized to obtain purified genetically engineered recombinant interferon (IFN). After washing with PBS, the immunomagnetic microspheres can be stored at 2-8°C and reused.
采用ELISA法测定纯化后的干扰素(IFN)免疫学活性,用细胞抑制病变法测定其生物学活性。纯化后干扰素(IFN)的各项纯度指标及动物源IgG含量均达到国家标准。直接纯化发酵菌体裂解液和经硫铵沉淀预处理的裂解液的干扰素(IFN)吸附量可达到9.6×105IU/ml和8.0×105IU/ml。用免疫磁性微球进行多次纯化实验,平均活性回收率大于50%,平均比活性大于1.0×108IU/mg。SDS-PAGE凝胶电泳分析免疫磁性分离纯化的干扰素(IFN)纯度接近100%。The immunological activity of purified interferon (IFN) was measured by ELISA method, and its biological activity was measured by cytostatic lesion method. The purity indexes of the purified interferon (IFN) and the content of animal-derived IgG all reached the national standard. The interferon (IFN) adsorption capacity of directly purified fermentation cell lysates and lysates pretreated by ammonium sulfate precipitation can reach 9.6×10 5 IU/ml and 8.0×10 5 IU/ml. Multiple purification experiments were carried out with immunomagnetic microspheres, the average activity recovery rate was greater than 50%, and the average specific activity was greater than 1.0×10 8 IU/mg. SDS-PAGE gel electrophoresis analysis showed that the purity of interferon (IFN) purified by immunomagnetic separation was close to 100%.
实施例一.Embodiment one.
一.抗IFNα-2b抗体IgG的制备:1. Preparation of anti-IFNα-2b antibody IgG:
1.抗血清的制备:1. Preparation of antiserum:
取1mg/mL的IFNα-2b标准品2mL,与等体积的弗氏完全佐剂充分混合乳化后得IFNα-2b乳化抗原。取2mL IFNα-2b的乳化抗原,分别对2只家兔(日本大耳白,雄性,体重2Kg)进行肌肉及皮下的多点注射。追加注射采用弗氏不完全佐剂乳化制备抗原,每隔两周加强注射一次,共三次,剂量递减。最后一次免疫6天后,腹动脉采血,将全血静置2小时,3000rpm离心20分钟,收集血清于55℃水浴中灭活30分钟,分装后于-20℃冷冻保存。Take 2 mL of 1 mg/mL IFNα-2b standard substance, mix well with an equal volume of Freund's complete adjuvant and emulsify to obtain IFNα-2b emulsified antigen. Take 2mL of the emulsified antigen of IFNα-2b, and inject multi-point intramuscularly and subcutaneously to 2 rabbits (Japanese big-eared white, male, body weight 2Kg). The additional injection was prepared by emulsifying the antigen with Freund's incomplete adjuvant, and the booster injection was performed once every two weeks, for a total of three times, with the dose decreasing. Six days after the last immunization, blood was collected from the abdominal artery. The whole blood was left to stand for 2 hours, centrifuged at 3000rpm for 20 minutes, and the serum was collected and inactivated in a water bath at 55°C for 30 minutes.
2.抗IFNα-2b IgG抗体的纯化:2. Purification of anti-IFNα-2b IgG antibody:
取抗IFNα-2b血清10mL,加入等体积的PBS混匀后,分别用50%和33%的饱和硫铵进行分级盐析,离心收集沉淀,沉淀物溶于PBS中,4℃透析过夜,得到粗提的抗IFNα-2b免疫球蛋白。将上述分级盐析的免疫球蛋白粗品,进行DEAE-cellulose 52离子交换层析,以0.02M PB缓冲液(pH8.0)洗脱,收集合并IgG组分,以去离子水透析,冷冻干燥后得精制兔抗IFNα-2b(Anti-IFNα-2b)IgG抗体,经SDS-PAGE检测为单一条带。Take 10 mL of anti-IFNα-2b serum, add an equal volume of PBS and mix well, carry out fractional salting out with 50% and 33% saturated ammonium sulfate respectively, collect the precipitate by centrifugation, dissolve the precipitate in PBS, and dialyze overnight at 4°C to obtain Crude anti-IFNα-2b immunoglobulin. The crude immunoglobulin obtained from the above graded salting-out was subjected to DEAE-cellulose 52 ion-exchange chromatography, eluted with 0.02M PB buffer (pH 8.0), and the combined IgG fraction was collected, dialyzed with deionized water, and freeze-dried The purified rabbit anti-IFNα-2b (Anti-IFNα-2b) IgG antibody was detected as a single band by SDS-PAGE.
二.琼脂糖免疫磁性微球的制备:2. Preparation of agarose immunomagnetic microspheres:
1.磁流体的制备:1. Preparation of ferrofluid:
取6克FeCl2·4H2O溶于400mL去离子水中,经微孔滤膜过滤除去杂质。然后加入150克聚乙二醇和100μL 30%H2O2混匀,用3M NaOH调溶液pH11,在50~60℃水浴中反应4小时,得到棕黑色磁性胶体粒子的稳定悬浮液即磁流体。6 g of FeCl 2 ·4H 2 O was dissolved in 400 mL of deionized water, and filtered through a microporous membrane to remove impurities. Then add 150 grams of polyethylene glycol and 100 μL of 30% H 2 O 2 and mix well, adjust the pH of the solution to 11 with 3M NaOH, and react in a water bath at 50-60°C for 4 hours to obtain a stable suspension of brown-black magnetic colloidal particles, that is, a magnetic fluid.
2.琼脂糖磁性微球的制备:2. Preparation of agarose magnetic microspheres:
在250ml三角瓶中加入75mL甲苯,30mL四氯化碳以及1.2mL Span-80,预热至70℃,作为有机相;取1克磁流体,加入到30mL 6%琼脂糖溶液中,于100℃水浴中加热溶解作为水相。将水相迅速转移至有机相中,3000rpm搅拌15分钟,然后迅速冷却至室温,得琼脂糖磁性微球。分别用乙醚、蒸馏水淋洗,筛分粒径范围在100~300μm之间的磁性微球,于4℃保存备用。Add 75mL toluene, 30mL carbon tetrachloride and 1.2mL Span-80 to a 250ml Erlenmeyer flask, preheat to 70°C, as the organic phase; take 1 g of magnetic fluid, add it to 30mL 6% agarose solution, at 100°C Heat and dissolve in a water bath as the water phase. The aqueous phase was quickly transferred to the organic phase, stirred at 3000 rpm for 15 minutes, and then rapidly cooled to room temperature to obtain agarose magnetic microspheres. Rinse with diethyl ether and distilled water respectively, sieve the magnetic microspheres with a particle size ranging from 100 to 300 μm, and store them at 4°C for later use.
3.琼脂糖磁性微球的活化和致敏:3. Activation and sensitization of agarose magnetic microspheres:
取琼脂糖磁性微球1mL,加入2mL 2M NaOH和1mL环氧氯丙烷,30℃下,振荡反应2小时,抽滤后分别用丙酮,蒸馏水清洗。加入10%氨水2mL,室温静置反应6小时。充分洗涤后,加入5%戊二醛2mL,室温振荡反应2小时,再用蒸馏水洗去过量的戊二醛,得活化的琼脂糖磁性微球。在上述微球1mL中加入5mL含有15mg Anti-IFNα-2b多克隆IgG抗体的0.1M NaHCO3-NaCO3缓冲液(pH9.6),4℃反应过夜。经PBS充分洗涤后,加入2mL0.5%NaBH4进行还原,再经PBS充分洗涤后即得到可用于纯化IFNα-2b的琼脂糖免疫磁性微球。用Lowry法测定抗体的偶联量为12.8mg/mL球。Take 1 mL of agarose magnetic microspheres, add 2 mL of 2M NaOH and 1 mL of epichlorohydrin, shake and react for 2 hours at 30 ° C, wash with acetone and distilled water after suction filtration. 2 mL of 10% ammonia water was added, and the reaction was allowed to stand at room temperature for 6 hours. After fully washing, add 2 mL of 5% glutaraldehyde, shake at room temperature for 2 hours, then wash off excess glutaraldehyde with distilled water to obtain activated agarose magnetic microspheres. Add 5 mL of 0.1 M NaHCO 3 -NaCO 3 buffer solution (pH 9.6) containing 15 mg of Anti-IFNα-2b polyclonal IgG antibody to 1 mL of the above-mentioned microspheres, and react overnight at 4°C. After fully washing with PBS, add 2mL of 0.5% NaBH 4 for reduction, and then fully wash with PBS to obtain agarose immunomagnetic microspheres that can be used to purify IFNα-2b. The coupling amount of antibody was determined by Lowry method to be 12.8 mg/mL ball.
三.α-2bIFN的免疫磁性分离:3. Immunomagnetic separation of α-2bIFN:
取致敏后的琼脂糖磁性微球1mL,置于磁性分离装置的玻璃容器中;取IFNα-2b发酵菌体裂解液1mL,10000rpm离心10分钟,取200μL上清液于10mL PBS中(稀释50倍),然后加入到玻璃容器中,于4℃缓慢振荡反应过夜。反应后将玻璃容器置于磁性分离装置上,吸附固定磁性微球,弃去反应液,然后用PBS清洗6次。再加入4mL 0.1M甘氨酸-盐酸缓冲液(pH2.5),4℃振荡2小时,解离被免疫磁性微球吸附的IFNα-2b。将玻璃容器置于分离装置上,吸附磁性微球,并收集解离液,立即用少量1M PB缓冲液(pH7.0)中和,得纯化的IFNα-2b。免疫磁性微球经PBS清洗后,于4℃保存,备再次使用。Take 1 mL of sensitized agarose magnetic microspheres and place them in the glass container of the magnetic separation device; take 1 mL of IFNα-2b fermentation cell lysate, centrifuge at 10,000 rpm for 10 minutes, and take 200 μL of supernatant in 10 mL of PBS (diluted 50 times), then added to a glass container, and reacted overnight at 4°C with slow shaking. After the reaction, the glass container was placed on a magnetic separation device, the magnetic microspheres were adsorbed and fixed, the reaction solution was discarded, and then washed 6 times with PBS. Add 4 mL of 0.1M glycine-hydrochloric acid buffer (pH 2.5) and shake at 4°C for 2 hours to dissociate the IFNα-2b adsorbed by the immunomagnetic microspheres. Place the glass container on the separation device, absorb the magnetic microspheres, collect the dissociated solution, and immediately neutralize it with a small amount of 1M PB buffer (pH 7.0) to obtain purified IFNα-2b. Immunomagnetic microspheres were washed with PBS and stored at 4°C for reuse.
采用ELISA法检测纯化后的IFNα-2b免疫学活性,用细胞抑制病变法测定其生物学活性。采用致敏的琼脂糖磁性微球直接纯化α-2bIFN发酵菌体裂解液,重复实验3次,平均吸附量为9.6×105IU/ml,平均活性回收率为88.2%,平均比活性为1.5×108IU/mg,经SDS-PAGE凝胶电泳进行纯度分析,纯度接近100%,各项指标及兔源IgG含量均达到国家标准,并显示了良好的重现性。The immunological activity of purified IFNα-2b was detected by ELISA method, and its biological activity was measured by cytostatic lesion method. Using sensitized agarose magnetic microspheres to directly purify the lysate of α-2bIFN fermented cells, repeated the experiment 3 times, the average adsorption capacity was 9.6×10 5 IU/ml, the average activity recovery rate was 88.2%, and the average specific activity was 1.5 ×10 8 IU/mg, analyzed by SDS-PAGE gel electrophoresis, the purity is close to 100%, all indicators and rabbit IgG content have reached the national standard, and showed good reproducibility.
实施例二.Embodiment two.
一.纤维素免疫磁性微球的制备:1. Preparation of cellulose immunomagnetic microspheres:
1.纤维素磁性微球的制备:1. Preparation of cellulose magnetic microspheres:
取100g脱脂棉用19%NaOH溶液800mL浸泡2小时,挤去碱液,25℃老化3天;加入50mL二硫化碳混匀,密封后28℃振荡反应5小时,再加入750~850mL的6%NaOH溶液混匀,28℃振荡5小时则得到橙红色黄原酸酯粘胶液。在500ml三颈瓶中加入180mL氯苯、30mL四氯化碳以及0.5克油酸钾,40℃水浴搅拌混匀作为有机相。取含有1克磁流体的黄原酸酯粘胶液70mL,加入到有机相中,3000rpm分散30分钟后,迅速升温至90℃,继续反应2小时,得纤维素磁性微球。分别用乙醚、蒸馏水淋洗,筛分筛选粒径在100~300μm之间的纤维素磁性微球,于4℃保存备用。Take 100g of absorbent cotton soaked in 800mL of 19% NaOH solution for 2 hours, squeeze out the lye, and age at 25°C for 3 days; add 50mL of carbon disulfide and mix well, seal and shake at 28°C for 5 hours, then add 750-850mL of 6% NaOH solution to mix Evenly, shake at 28°C for 5 hours to obtain orange-red xanthate viscose. Add 180mL of chlorobenzene, 30mL of carbon tetrachloride and 0.5g of potassium oleate into a 500ml three-neck flask, stir and mix in a water bath at 40°C as the organic phase. Take 70 mL of xanthate viscose solution containing 1 gram of magnetic fluid, add it to the organic phase, disperse at 3000 rpm for 30 minutes, then rapidly raise the temperature to 90° C., and continue to react for 2 hours to obtain cellulose magnetic microspheres. Rinse with ether and distilled water respectively, sieve and screen the cellulose magnetic microspheres with a particle size between 100 and 300 μm, and store them at 4°C for later use.
2.纤维素磁性微球的活化和致敏:2. Activation and sensitization of cellulose magnetic microspheres:
取纤维素磁性微球1mL,加入2mL 3M NaOH和1mL环氧氯丙烷,40℃下振荡反应2.5小时,抽滤后分别用丙酮,蒸馏水清洗。加入4mL 5%氨水,室温静置反应9小时。充分洗涤后加入5mL 2%戊二醛,室温振荡5小时,再用蒸馏水洗去过量的戊二醛,得活化的纤维素磁性微球。在上述微球1mL中加入5mL含有12mg Anti-IFNα-2bIgG多克隆抗体的0.1MNaHCO3-NaCO3缓冲液(pH9.6),4℃反应过夜。经PBS充分洗涤后,加入2mL 0.5%NaBH4进行还原,再经PBS充分洗涤后即得到可用于纯化IFNα-2b的纤维素免疫磁性微球。用Lowry法测定抗体的偶联量为11.8mg/mL球。Take 1 mL of cellulose magnetic microspheres, add 2 mL of 3M NaOH and 1 mL of epichlorohydrin, shake and react at 40°C for 2.5 hours, wash with acetone and distilled water after suction filtration. 4 mL of 5% ammonia water was added, and the reaction was allowed to stand at room temperature for 9 hours. After fully washing, add 5 mL of 2% glutaraldehyde, shake at room temperature for 5 hours, and then wash off excess glutaraldehyde with distilled water to obtain activated cellulose magnetic microspheres. Add 5 mL of 0.1M NaHCO 3 -NaCO 3 buffer solution (pH 9.6) containing 12 mg of Anti-IFNα-2bIgG polyclonal antibody to 1 mL of the above-mentioned microspheres, and react overnight at 4°C. After being fully washed with PBS, 2 mL of 0.5% NaBH 4 was added for reduction, and then fully washed with PBS to obtain cellulose immunomagnetic microspheres that can be used for purifying IFNα-2b. The coupling amount of the antibody was determined by the Lowry method to be 11.8 mg/mL ball.
二.α-2bIFN的免疫磁性分离:2. Immunomagnetic separation of α-2bIFN:
取纤维素磁性微球1mL,置于磁性分离装置的玻璃容器中;取α-2bIFN发酵菌体裂解液5mL,10000rpm离心10分钟,再取上清液加入等体积的PBS混匀,缓慢加入等体积预冷的饱和硫铵溶液,混匀,置于冰浴上,放置4小时。4℃,6000rpm离心15分钟,弃上清液,沉淀溶于5ml PBS,用0.1M PBS透析,取500μL透析液于10mL PBS中(稀释20倍),然后加入到玻璃容器中,于4℃缓慢振荡反应过夜。反应后将玻璃容器置于磁性分离装置上,吸附固定磁性微球,弃去反应液,然后用PBS清洗5次。再加入4mL 0.1M甘氨酸-盐酸缓冲液(pH2.5),4℃振荡2小时,解离被免疫磁性微球吸附的IFNα-2b。将玻璃容器置于分离装置上,吸附磁性微球,并收集解离液,立即用少量1M PB缓冲液(pH7.0)中和,得纯化的IFNα-2b。免疫磁性微球经PBS清洗后,于4℃保存,备再次使用。Take 1mL of cellulose magnetic microspheres and place them in the glass container of the magnetic separation device; take 5mL of α-2bIFN fermentation cell lysate, centrifuge at 10,000rpm for 10 minutes, then take the supernatant and add an equal volume of PBS to mix, slowly add etc. Volume of pre-cooled saturated ammonium sulfate solution, mix well, place on ice bath, stand for 4 hours. Centrifuge at 6000rpm at 4°C for 15 minutes, discard the supernatant, dissolve the pellet in 5ml PBS, dialyze with 0.1M PBS, take 500μL dialysate in 10mL PBS (diluted 20 times), then add it to a glass container, and slowly Shake the reaction overnight. After the reaction, the glass container was placed on a magnetic separation device, the magnetic microspheres were adsorbed and fixed, the reaction solution was discarded, and then washed 5 times with PBS. Add 4 mL of 0.1M glycine-hydrochloric acid buffer (pH 2.5) and shake at 4°C for 2 hours to dissociate the IFNα-2b adsorbed by the immunomagnetic microspheres. Place the glass container on the separation device, absorb the magnetic microspheres, collect the dissociated solution, and immediately neutralize it with a small amount of 1M PB buffer (pH 7.0) to obtain purified IFNα-2b. Immunomagnetic microspheres were washed with PBS and stored at 4°C for reuse.
采用ELISA法检测纯化后的IFNα-2b免疫学活性,用细胞抑制病变法测定其生物学活性。采用致敏的纤维素磁性微球纯化经硫胺沉淀预处理后的IFNα-2b发酵菌体裂解液,重复实验3次,平均吸附量为8.0×105IU/ml,平均活性回收率为50.3%,平均比活性为1.4×108IU/mg,经SDS-PAGE凝胶电泳进行纯度分析,纯度接近100%,各项指标及兔源IgG含量均达到国家标准,并显示了良好的重现性。The immunological activity of purified IFNα-2b was detected by ELISA method, and its biological activity was measured by cytostatic lesion method. Using sensitized cellulose magnetic microspheres to purify the lysate of IFNα-2b fermented cells pretreated by thiamine precipitation, the experiment was repeated three times, the average adsorption capacity was 8.0×10 5 IU/ml, and the average activity recovery rate was 50.3 %, the average specific activity is 1.4×10 8 IU/mg, the purity is analyzed by SDS-PAGE gel electrophoresis, the purity is close to 100%, all the indicators and rabbit IgG content have reached the national standard, and have shown good reproducibility sex.
实施例三.Embodiment three.
一.聚乙烯醇免疫磁性微球的制备:1. Preparation of polyvinyl alcohol immunomagnetic microspheres:
1.聚乙烯醇磁性微球的制备:1. Preparation of polyvinyl alcohol magnetic microspheres:
在500ml三颈瓶中加入140mL 200#汽油、110mL四氯化碳以及5mL Span-80混匀作为有机相;配制10%聚乙烯醇50ml,加入0.6克磁流体后冰浴15分钟,再加入25%戊二醛5mL和1N HCL 6mL;混匀后迅速加入有机相中,3000rpm搅拌30分钟,然后升温至70℃,继续搅拌反应2小时,得聚乙烯醇磁性微球。分别用乙醚、蒸馏水淋洗,筛选粒径在100~300μm之间的聚乙烯醇磁性微球,于4℃保存备用。Add 140mL 200 # gasoline, 110mL carbon tetrachloride and 5mL Span-80 into a 500ml three-necked bottle and mix well as the organic phase; prepare 50ml of 10% polyvinyl alcohol, add 0.6g of magnetic fluid and ice bath for 15 minutes, then add 25 % glutaraldehyde 5mL and 1N HCL 6mL; after mixing, quickly add to the organic phase, stir at 3000rpm for 30 minutes, then raise the temperature to 70°C, continue to stir and react for 2 hours to obtain polyvinyl alcohol magnetic microspheres. Rinse with ether and distilled water respectively, screen the polyvinyl alcohol magnetic microspheres with a particle size between 100 and 300 μm, and store them at 4°C for later use.
2.聚乙烯醇磁性微球的活化和致敏:2. Activation and sensitization of polyvinyl alcohol magnetic microspheres:
取聚乙烯醇磁性微球1ml,加入10mL二甲基亚砜和3mL环氧氯丙烷,40℃,缓慢滴加2M NaOH 10mL,继续反应4小时后,抽滤,分别用丙酮,蒸馏水清洗。加入1.5mL15%氨水,室温静置反应3小时。充分洗涤后加入1mL 10%戊二醛,室温振荡1小时,再用蒸馏水洗去过量的戊二醛,得活化的聚乙烯醇磁性微球。在上述微球1mL中加入5mL含有8mgAnti-IFNα-2b Mab IgG抗体的0.1M NaHCO3-NaCO3缓冲液(pH9.6),4℃反应过夜。经PBS充分洗涤后,加入2mL 0.5%NaBH4进行还原,再经PBS充分洗涤后即得到可用于纯化IFNα-2b的聚乙烯醇免疫磁性微球。用Lowry法测定抗体的偶联量为3.7mg/mL球。Take 1ml of polyvinyl alcohol magnetic microspheres, add 10mL of dimethyl sulfoxide and 3mL of epichlorohydrin, slowly add 10mL of 2M NaOH dropwise at 40°C, continue to react for 4 hours, filter with suction, and wash with acetone and distilled water respectively. Add 1.5 mL of 15% ammonia water and let it stand at room temperature for 3 hours. After thorough washing, add 1 mL of 10% glutaraldehyde, shake at room temperature for 1 hour, and then wash off excess glutaraldehyde with distilled water to obtain activated polyvinyl alcohol magnetic microspheres. Add 5 mL of 0.1 M NaHCO 3 -NaCO 3 buffer solution (pH 9.6) containing 8 mg of Anti-IFNα-2b Mab IgG antibody to 1 mL of the above-mentioned microspheres, and react overnight at 4°C. After being fully washed with PBS, 2 mL of 0.5% NaBH 4 was added for reduction, and then fully washed with PBS to obtain polyvinyl alcohol immunomagnetic microspheres that can be used for purifying IFNα-2b. The coupling amount of antibody determined by Lowry method was 3.7mg/mL ball.
二.α-2bIFN的免疫磁性分离:2. Immunomagnetic separation of α-2bIFN:
取聚乙烯醇磁性微球1mL,置于磁性分离装置的玻璃容器中;取α-2bIFN发酵菌体裂解液1mL,10000rpm离心10分钟,取100μL上清液于10mL PBS中(稀释100倍),然后加入到玻璃容器中,于4℃缓慢振荡反应过夜。反应后将玻璃容器置于磁性分离装置上,吸附固定磁性微球,弃去反应液,然后用PBS清洗6次。再加入4mL 0.1M甘氨酸-盐酸缓冲液(pH2.5),4℃振荡2小时,解离被免疫磁性微球吸附的IFNα-2b。将玻璃容器置于分离装置上,吸附磁性微球,并收集解离液,立即用少量1M PB缓冲液(pH7.0)中和,得纯化的IFNα-2b。免疫磁性微球经PBS清洗后,于4℃保存,备再次使用。Take 1mL of polyvinyl alcohol magnetic microspheres and place them in the glass container of the magnetic separation device; take 1mL of α-2bIFN fermentation cell lysate, centrifuge at 10000rpm for 10 minutes, take 100μL of supernatant in 10mL of PBS (diluted 100 times), Then it was added into a glass container and reacted overnight at 4°C with slow shaking. After the reaction, the glass container was placed on a magnetic separation device, the magnetic microspheres were adsorbed and fixed, the reaction solution was discarded, and then washed 6 times with PBS. Add 4 mL of 0.1M glycine-hydrochloric acid buffer (pH 2.5) and shake at 4°C for 2 hours to dissociate the IFNα-2b adsorbed by the immunomagnetic microspheres. Place the glass container on the separation device, absorb the magnetic microspheres, collect the dissociated solution, and immediately neutralize it with a small amount of 1M PB buffer (pH 7.0) to obtain purified IFNα-2b. Immunomagnetic microspheres were washed with PBS and stored at 4°C for reuse.
采用ELISA法检测纯化后的IFNα-2b免疫学活性,用细胞抑制病变法测定其生物学活性。采用致敏的聚乙烯醇磁性微球直接纯化α-2bIFN发酵菌体裂解液,重复实验3次,平均吸附量为4.5×105IU/ml,平均活性回收率为93.9%,平均比活性为1.2×108IU/mg,经SDS-PAGE凝胶电泳进行纯度分析,纯度接近100%,各项指标及鼠源IgG含量均达到国家标准,并显示了良好的重现性。The immunological activity of purified IFNα-2b was detected by ELISA method, and its biological activity was measured by cytostatic lesion method. Using sensitized polyvinyl alcohol magnetic microspheres to directly purify the lysate of α-2bIFN fermented cells, repeated the experiment three times, the average adsorption capacity was 4.5×10 5 IU/ml, the average activity recovery rate was 93.9%, and the average specific activity was 1.2×10 8 IU/mg, analyzed by SDS-PAGE gel electrophoresis, the purity is close to 100%, all indicators and mouse IgG content reach the national standard, and show good reproducibility.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 03144274 CN1229389C (en) | 2003-09-15 | 2003-09-15 | Immunomagnetic Separation Technology of Purifying Gene Engineering Recombinant Interferon |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 03144274 CN1229389C (en) | 2003-09-15 | 2003-09-15 | Immunomagnetic Separation Technology of Purifying Gene Engineering Recombinant Interferon |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1524878A CN1524878A (en) | 2004-09-01 |
CN1229389C true CN1229389C (en) | 2005-11-30 |
Family
ID=34286599
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 03144274 Expired - Fee Related CN1229389C (en) | 2003-09-15 | 2003-09-15 | Immunomagnetic Separation Technology of Purifying Gene Engineering Recombinant Interferon |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1229389C (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101092614B (en) * | 2007-05-23 | 2011-06-01 | 南开大学 | A preparation method and application of immunomagnetic microspheres for separating and immobilizing enzymes |
CN101274985B (en) * | 2008-05-12 | 2011-04-20 | 武汉大学 | Magnetic cellulose microsphere, preparation thereof and use thereof |
CN101782578B (en) * | 2009-01-21 | 2013-02-06 | 王树森 | Preparation method and application of immunomagnetic microspheres coated with staphylococal protein |
CN104475041A (en) * | 2014-10-22 | 2015-04-01 | 哈尔滨工业大学 | A novel method of preparing agarose magnetic microspheres and uses of the agarose magnetic microspheres in separation and purification of an IgG antibody |
CN105170042B (en) * | 2015-09-17 | 2017-10-20 | 湖州师范学院 | A kind of method of the antibody separation based on magnetic microsphere |
CN108414305B (en) * | 2018-01-24 | 2020-08-04 | 广州市丰华生物工程有限公司 | Sample processing method and treating agent for determination of tuberculosis infection T cells |
CN108287235B (en) * | 2018-02-07 | 2021-03-09 | 常州天地人和生物科技有限公司 | Preparation and application of efficient and stable magnetic immune microspheres |
-
2003
- 2003-09-15 CN CN 03144274 patent/CN1229389C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1524878A (en) | 2004-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1925898A (en) | Antibody purification technique | |
CN101602805B (en) | Agarose compatible medium for purifying immune globulin of hand-foot-and-mouth disease and preparation method thereof | |
CN104096544A (en) | Chromatographic medium using amino benzimidazole as function ligand and preparation method thereof | |
CN1496993A (en) | Albumin purifaction | |
CN1229389C (en) | Immunomagnetic Separation Technology of Purifying Gene Engineering Recombinant Interferon | |
CN101092614B (en) | A preparation method and application of immunomagnetic microspheres for separating and immobilizing enzymes | |
CN103212377A (en) | Preparation method of agarose immune magnetic microspheres and applications thereof | |
CN1563090A (en) | High performance quick purifying method for preparing piecewise antibody | |
JPS5821691A (en) | Purifying method of interferon | |
JPS6262153B2 (en) | ||
CN101260145B (en) | A separation and purification process of recombinant human serum albumin and its fusion protein | |
EP3578255A1 (en) | High-loading and alkali-resistant protein a magnetic bead and method of use thereof | |
CN101033254A (en) | Method of purifying and combining human interleukins 12 | |
WO1984001289A1 (en) | Purified and antigenically selective vaccines for domestic animals | |
CN111659355A (en) | Alkylation modified hepatitis B virus immunoadsorbent and preparation method thereof | |
CN111333776B (en) | Nitrogen heterocyclic organic polymer integral material, preparation and application | |
CN108611327A (en) | A kind of isolation and purification method of 2 porcine circovirus virus-like particle | |
CN101885767A (en) | Method for separating and purifying recombinant human interferon alpha 1b instead of monoclonal antibody affinity chromatography | |
CN1064968C (en) | Process of extracting and purifying recombined protein | |
CN1262278A (en) | Process for separating and purifying FSH and corpus luteum hormone | |
CN101060931A (en) | Antibodies by chromatography | |
CN1687115A (en) | Agglutinin protein of astragalus root and preparation method thereof | |
CN1811410A (en) | Affinity chromatograph filling and producing process and application thereof | |
EP4169938A1 (en) | Method for purifying recombinant protein | |
CN1958599A (en) | Method for enriching and purifying glycosylation protein |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Tianjin Hualida Biological Engineering Co., Ltd. Assignor: Nankai University Contract record no.: 2010120000127 Denomination of invention: Immunization magnetic separation technology for purifying genetic engineering recombinant interferon Granted publication date: 20051130 License type: Exclusive License Open date: 20040901 Record date: 20100921 |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20051130 Termination date: 20140915 |
|
EXPY | Termination of patent right or utility model |